Skip to main content

Table 4 Biological tolerance to the two ACTs on days 0 and 7

From: A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire

 

Day

Artemisinine/naphtoquine

Artemather/lumefantrine

Aneamia

0

29/60

23/60

(Hb < 11 g/d)

 

48.3%

38.3%

 

7

36/60

34

  

60%

56.7%

Craetinemia > 14

0

0/60

1/60

  

0%

1.7%

 

7

0/60

1/60

  

0%

1.7%

SGOT > 48

0

0/60

0/60

  

0%

0%

 

7

0/60

0/60

  

0%

0%

SGPT > 45

0

0/60

1/60

  

0%

1.7%

 

7

0/60

1/60

  

0%

1.7%

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us